Pfizer spinoff Zoetis ups 2017 guidance, eyes more M&A for future growth
admin 8th August 2017 Uncategorised 0What does Pfizer animal health spinoff Zoetis share with its former parent, aside from its lineage? They’re both under pressure from investors to drive growth through acquisitions. Zoetis met second-quarter expectations and brightened its forecast for the rest of the year, and now it’s looking to M&A to drive further growth.
More: Pfizer spinoff Zoetis ups 2017 guidance, eyes more M&A for future growth
Source: fierce